Nominate the deserving nurse in your life for an Oncology Nursing Award. Submissions due September 30, 2019.
Awards
The world of oncology nursing is constantly changing. Here’s a simplified way to search our resources for up-to-date information.
Explore Resources
Find CNE contact hours, certification preparation, scholarship details, career advice, and opportunities to grow professionally.
Help us to continuously improve the quality of cancer care, and the lives of every nurse who provides it.
Join or Renew Your ONS MembershipWe are students, clinicians, scientists, educators, and mentors working together to transform the way the world cares for cancer.
On September 17, 2019, the U.S. Food and Drug Administration (FDA) approved apalutamide (ErleadaTM) for patients with metastatic castration-sensitive prostate cancer. Apalutamide was initially approved in 2018 for patients with non-metastatic castration-resistant prostate cancer.
